:: Altroz - News Magazine HTML Template ::

Language:

USFDA News

Laurus Labs Faces USFDA Scrutiny: A Closer Look at the Recent Form 483 Observation

Christopher Adams 23 Jan, 2025

Laurus Labs' US subsidiary, Laurus Generics Inc, received a Form 483 with one observation from the USFDA following a detailed inspection. The company is committed to addressing the...

Business

Aurobindo Pharma's Hyderabad API Unit Faces USFDA Inspection with Two Observations

Ryan Peterson 18 Dec, 2024

Aurobindo Pharma reports that the USFDA inspected its subsidiary Apitoria Pharma's API manufacturing facility in Hyderabad with two procedural observations, to be addressed within ...

USFDA News

Laurus Labs Faces USFDA Scrutiny: A Closer Look at the Recent Form 483 Observation

Aurobindo Pharma's Hyderabad API Unit Faces USFDA Inspection with Two Observations

Popular News

Standard Glass Sets IPO Price Band at Rs 133-140, Opening January 6

Vietnam's Shrimp Exports Poised to Bounce Back to $4 Billion in 2024

Quantit and Bareksa Join Forces to Revolutionize AI-Powered Investment in Indonesia

Festive Cheer Drives India's Industrial Output to 3.7% Growth in October

How Air India Navigates the Falling Rupee: A Strategic Hedge in International Flights

Congo's Bold Move: Criminal Complaints Against Apple Over Conflict Minerals

Urgent Call to Action: Experts Advocate for Increased Aluminium Import Duties to Safeguard Domestic Industry

South Korea Announces Historic Won-Denominated Forex Stabilization Bonds After 22 Years

Newsletter

Subscribe Newsletter!

Privacy Policy

Terms & Conditions

Contact Us